Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy
Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy
批准号:
8404023
负责人:
Konstantin V Sokolov
金额:
$28.27万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-01 至 2014-12-31
关键词:
AdsorptionAnimalsArchitectureAreaAvidityBiodegradationBiodistributionBiologicalBiological AssayBiological MarkersBiomedical EngineeringCaliberCancerousCellsChargeCluster AnalysisColloidsCoupledDataDetectionDevelopmentDiagnosisDiseaseDrug FormulationsEndocytosisEnvironmentEvaluationExcretory functionExhibitsExtinction (Psychology)FecesGoalsGoldGrowthHybridsImageImage EnhancementIn VitroIndividualInjection of therapeutic agentInternationalInvestigationLegal patentLengthLifeLigandsLinkLongitudinal StudiesMagnetic Resonance ImagingMalignant NeoplasmsManuscriptsMass Spectrum AnalysisMeasurementMediatingMedicalMetabolicMetabolic Clearance RateMetalsMethodologyMethodsModelingModern MedicineMolecularMolecular TargetMonitorNanotechnologyNatureNear-Infrared SpectroscopyOpticsOrganPathologyPathway interactionsPeptide antibodiesPhysiologicalPlasmaPolymersPorosityPreparationProceduresProcessPropertyPublishingQuantum DotsResearchRoentgen RaysRouteScanning Electron MicroscopyScienceShapesSignal TransductionSilverSiteSliceSolutionsSolventsSpecificitySurfaceTestingTherapeuticTimeTissue SampleTissuesToxic effectTranslationsTransmission Electron MicroscopyUrineValidationWorkabsorptionacoustic imagingbasebiodegradable polymerbioimagingcancer cellcancer imagingcancer therapycarcinogenesiscellular imagingclinical practicedesignevaporationexperiencein vivointerestintermolecular interactioniron oxidelight scatteringmacrophagemalignant mouth neoplasmmeetingsmembernanocagenanocompositenanomaterialsnanoparticlenanorodnanoshellnoveloptical imagingparticlephotoacoustic imagingplasmonicsprogramspublic health relevancesimulationskillssoft tissuetargeted deliverytime usetumorurinaryzeta potential
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It has been convincingly shown that nanotechnology can provide unique solutions to revolutionize diagnosis and treatment of many devastating diseases such as cancer. One specific area of great interest is development of nanoparticles for molecular specific imaging, therapy and combined imaging/therapy. A major roadblock in translation of inorganic nanoparticles to clinical practice for systemic targeting of cancer cells is their non-biodegradable nature. In addition, sizes of coated nanoparticles that are used in biological applications are not small enough to be easily cleared from the body. The accumulation and resulting long- term toxicity of nanoparticles is a major concern. In this research program we will create a new class of biodegradable gold nanoparticles with plasmon resonances in the NIR region. The nanoparticles will degrade to easily clearable components in the body and, therefore, will provide a crucial missing link between the enormous potential of metal nanoparticles for cancer imaging and therapy and translation into clinical practice. Our synthetic methodology is based on controlled assembly of very small (less than 5 nm) primary gold particles into nanoclusters with <100 nm overall diameter and an intense NIR absorbance. The assembly will be mediated by biodegradable polymers and small capping ligands on the primary nanoparticles. After delivery into the body the nanoclusters will biodegrade over time into sub-6 nm ligand capped primary gold nanoparticles, which will be highly favorable for rapid clearance from the body. This hybrid polymer/inorganic material will combine advantages of biodegradability of polymer nanoparticles and strong imaging contrast and therapeutic capabilities afforded by metal nanoparticles. Whereas these nanoclusters will be shown to have widespread potential in imaging/therapy, we will develop and optimize in this particular application biodegradable plasmonic nanoclusters with intense NIR absorbance for photo-acoustic imaging (PA) of cancerous cells. The nanoclusters will be evaluated in biologically relevant models of oral cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
iThera Medical Multispectral Optoacoustic Tomography System for Full Body Molecular and Functional Small Animal Imaging
-
批准号:8825823
-
项目类别:
-
资助金额:$50.19万
-
财政年份:2015
-
负责人:Konstantin V Sokolov
-
依托单位:
Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy
-
批准号:8205011
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2010
-
负责人:Konstantin V Sokolov
-
依托单位:
Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy
-
批准号:8010637
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2010
-
负责人:Konstantin V Sokolov
-
依托单位:
Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
-
批准号:7909734
-
项目类别:
-
资助金额:$13.97万
-
财政年份:2009
-
负责人:Konstantin V Sokolov
-
依托单位:
Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
-
批准号:7514833
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2008
-
负责人:Konstantin V Sokolov
-
依托单位:
Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
-
批准号:7644393
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2008
-
负责人:Konstantin V Sokolov
-
依托单位:
Polarization Spectroscopy and Imaging of Pre-Cancer
-
批准号:7064822
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2005
-
负责人:Konstantin V Sokolov
-
依托单位:
Polarization Spectroscopy and Imaging of Pre-Cancer
-
批准号:7345411
-
项目类别:
-
资助金额:$23.87万
-
财政年份:2005
-
负责人:Konstantin V Sokolov
-
依托单位:
Polarization Spectroscopy and Imaging of Pre-Cancer
-
批准号:6928095
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2005
-
负责人:Konstantin V Sokolov
-
依托单位:
Polarization Spectroscopy and Imaging of Pre-Cancer
-
批准号:7187356
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2005
-
负责人:Konstantin V Sokolov
-
依托单位:
海外基金